SNIFF - Combo INI+EMPA Trial
Conditions: Mild Cognitive Impairment; Cognitive Impairment; Alzheimer Disease Interventions: Drug: Insulin (Humulin® R U-100); Drug: Empagliflozin 10 MG; Device: Aptar Pharma CPS Intranasal Delivery Device; Drug: Placebo (Insulin Diluent); Drug: Placebo (Capsules) Sponsor: Wake Forest University Health Sciences Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Pharmaceuticals | Research